RxSight Return on Equity (ROE) Growth & History (RXST)
RxSight's return on equity was −13.99% for fiscal 2025.
View full RxSight company overviewRxSight annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −13.99% | −1.55 pp |
| 2024 | 2024-12-31 | −12.43% | +26.41 pp |
| 2023 | 2023-12-31 | −38.85% | +19.68 pp |
| 2022 | 2022-12-31 | −58.52% | — |
RxSight quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −4.56% | −0.33 pp |
| Q1 2026 | 2026-03-31 | −5.85% | −2.93 pp |
| Q4 2025 | 2025-12-31 | −3.32% | −1.19 pp |
| Q3 2025 | 2025-09-30 | −3.54% | −1.25 pp |
| Q2 2025 | 2025-06-30 | −4.23% | −1.46 pp |
| Q1 2025 | 2025-03-31 | −2.92% | +2.69 pp |
| Q4 2024 | 2024-12-31 | −2.13% | +3.58 pp |
| Q3 2024 | 2024-09-30 | −2.29% | +5.50 pp |
| Q2 2024 | 2024-06-30 | −2.77% | +6.37 pp |
| Q1 2024 | 2024-03-31 | −5.61% | +5.64 pp |
| Q4 2023 | 2023-12-31 | −5.70% | +11.09 pp |
| Q3 2023 | 2023-09-30 | −7.79% | +8.54 pp |
| Q2 2023 | 2023-06-30 | −9.14% | +5.22 pp |
| Q1 2023 | 2023-03-31 | −11.25% | +2.21 pp |
| Q4 2022 | 2022-12-31 | −16.80% | −5.91 pp |
| Q3 2022 | 2022-09-30 | −16.33% | — |
| Q2 2022 | 2022-06-30 | −14.35% | — |
| Q1 2022 | 2022-03-31 | −13.46% | — |
| Q4 2021 | 2021-12-31 | −10.88% | — |
RxSight return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, RxSight's return on equity increased from −58.52% to −13.99%, a change of +44.54 percentage points. The latest reported quarter, Q2 2026, shows −4.56%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RxSight source filings ↗